An elevated albumin-bilirubin (ALBI) score ≥2.27 was associated with significantly higher in-hospital mortality in patients with heart failure (OR 1.671; 95% CI 1.228-2.274; p=0.001).
Cohort (n=9,749)
Does the albumin-bilirubin (ALBI) score predict in-hospital mortality in patients with heart failure?
The ALBI score is an independent predictor of in-hospital mortality in heart failure patients and enhances the prognostic value of NT-proBNP.
Odds Ratio: 1.671 (95% CI 1.228–2.274)
p-value: p=0.001
OBJECTIVES: Liver dysfunction is prevalent in patients with heart failure (HF) and can lead to poor prognosis. The albumin-bilirubin (ALBI) score is considered as an effective and convenient scoring system for assessing liver function. We analysed the correlation between ALBI and in-hospital mortality in patients with HF. DESIGN: A retrospective cohort study. SETTING AND PARTICIPANTS: A total of 9749 patients with HF (from January 2013 to December 2018) was enrolled and retrospectively analysed. MAIN OUTCOME MEASURES: The main outcome is in-hospital mortality. RESULTS: bilirubin umol/L * 0.66) + (albumin g/L * -0.085), and analysed as a continuous variable as well as according to three categories. Following adjustment for multivariate analysis, patients which occurred in-hospital death was remarkably elevated in tertile 3 group (ALBI ≥2.27) (OR 1.671, 95% CI 1.228 to 2.274, p=0.001), relative to the other two groups (tertile 1: ≤2.59; tertile 2: -2.59 to -2.27). Considering ALBI score as a continuous variable, the in-hospital mortality among patients with HF increased by 8.2% for every 0.1-point increase in ALBI score (OR 1.082; 95% CI 1.052 to 1.114; p<0.001). The ALBI score for predicting in-hospital mortality under C-statistic was 0.650 (95% CI 0.641 to 0.660, p<0.001) and the cut-off value of ALBI score was -2.32 with a specificity of 0.630 and a sensitivity of 0.632. Moreover, ALBI score can enhance the predictive potential of NT-pro-BNP (NT-pro-BNP +ALBI vs NT-pro-BNP: C-statistic: z=1.990, p=0.0467; net reclassification improvement=0.4012, p<0.001; integrated discrimination improvement=0.0082, p<0.001). CONCLUSIONS: In patients with HF, the ALBI score was an independent prognosticator of in-hospital mortality. The predictive significance of NT-proBNP +ALBI score was superior to NT-proBNP, and ALBI score can enhance the predictive potential of NT-proBNP.
Su et al. (Sat,) conducted a cohort in Heart failure (n=9,749). Albumin-bilirubin (ALBI) score vs. Lower ALBI score categories (tertile 1 and 2) was evaluated on In-hospital mortality (OR 1.671, 95% CI 1.228 to 2.274, p=0.001). An elevated albumin-bilirubin (ALBI) score ≥2.27 was associated with significantly higher in-hospital mortality in patients with heart failure (OR 1.671; 95% CI 1.228-2.274; p=0.001).